Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AM

AMRX

Market Closed

Amneal Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic
US
8.50K employees
CEO: Chirag K. Patel
Founded: 2018
$18.07
+$0.00(+NaN%)
Market Cap
5.77B
Beta
1.26
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Financial Statements
Comprehensive breakdown of financial statements and performance metrics
Gross Margin
37.6%
11.3%
CAGR: 10.2%

Profit after direct costs

Operating Margin
14.0%
69.7%
CAGR: 29.0%

Core business profitability

Net Margin
2.4%
-161.6%
CAGR: 61.4%

Bottom line profitability

Revenue Growth
8.0%
YoY
CAGR: 9.6%

Top line growth rate

Revenue Flow Analysis
Visual flow showing how AMRX allocates revenue across expenses and profit
Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin
37.6%
$1.14B
Operating Margin
14.0%
$423.09M
Net Margin
2.4%
$72.06M
Detailed Income Statement
Complete profit and loss breakdown with margin analysis and historical comparison
ItemTrend20212022202320242025YoY Change
Total Revenue
2.09B2.21B2.39B2.79B3.02B8.0%
Cost of Revenue
(1.32B)(1.42B)(1.53B)(1.77B)(1.88B)6.2%
Gross Profit
768.97M791.46M863.87M1.02B1.14B11.3%
Operating Expenses
Research & Development
(209.56M)(208.66M)(194.75M)(190.71M)(186.18M)-2.4%
Selling, General & Administrative
(365.50M)(399.70M)(429.68M)(476.44M)(526.83M)10.6%
Depreciation & Amortization
(233.41M)(240.18M)(229.40M)(236.19M)(223.57M)-5.3%
Operating Income (EBIT)
152.72M-94.93M204.37M249.33M423.09M69.7%
Non-Operating Items
Interest Income
——————
Interest Expense
(136.32M)(158.38M)(210.63M)(258.60M)(241.09M)-6.8%
Other Income/Expenses (Net)
-121.35M-153.20M-244.64M-304.34M-283.88M-6.7%
Income Before Tax
31.37M-248.13M-40.27M-55.01M139.21M-353.0%
Income Tax Expense
(11.20M)(6.66M)(8.45M)(18.86M)(11.28M)-40.2%
Net Income
10.62M-129.99M-83.99M-116.89M72.06M-161.6%
Per Share Metrics
Earnings Per Share (Basic)
$0$-1$-0$-0$0-160.5%
Weighted Avg Shares Outstanding
148.92M150.94M174.99M308.98M313.37M1.4%
Weighted Avg Shares Outstanding (Diluted)
151.82M150.94M176.14M308.98M324.81M5.1%
EBITDA
401.10M440.21M500.78M439.77M603.87M37.3%

Explore AMRX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AMRX in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →